Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- TD Cowen analyst Ritu Baral initiated coverage on Akero Therapeutics, Inc. (NASDAQ:AKRO) with a Buy rating and announced a price target of $76. Akero Therapeutics shares closed at $48.37 on Friday. See how other analysts view this stock.
- JMP Securities analyst Trevor Walsh initiated coverage on AeroVironment, Inc. (NASDAQ:AVAV) with a Market Outperform rating and announced a price target of $325. AeroVironment shares closed at $260.07 on Friday. See how other analysts view this stock.
- Canaccord Genuity analyst Whitney Ijem initiated coverage on Wave Life Sciences Ltd. (NASDAQ:WVE) with a Buy rating and announced a price target of $19. WAVE Life Sciences shares closed at $8.63 on Friday. See how other analysts view this stock.
- LifeSci Capital analyst Sam Slutsky initiated coverage on Palvella Therapeutics, Inc. (NASDAQ:PVLA) with an Outperform rating and announced a price target of $90. Palvella Therapeutics shares closed at $36.55 on Friday. See how other analysts view this stock.
- UBS analyst Paul Gong initiated coverage on WeRide Inc. (NASDAQ:WRD) with a Buy rating and announced a price target of $12. WeRide shares closed at $8.65 on Friday. See how other analysts view this stock.
Considering buying AVAV stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock
